Press Releases

NDA Group Names New Chief Financial Officer to Lead Financial Strategy and Growth

NDA Group announces the appointment of Erik Bech-Jansen as the new Chief Financial Officer.

BOC Sciences Live Webinar on Sensitive Nucleic Acids: Applications and Chemical Synthesis

Professor Shiyue Fang from the Department of Chemistry, Michigan Technological University, accepted BOC Sciences' invitation to present his insightful ideas about sensitive nucleic acid applications and chemical synthesis.

BOC Sciences January 2023 Promo: An Economical (Bio)chemical Source for New Year Projects

As the new year approaches, BOC Sciences' January promotion is bang on time, as usual, to thank all regular customers for the year-round support and to welcome new partners to join.

Contract Research Organizations Gain Competitive Edge with Oracle Cloud Oracle

While increased investment in pharmaceutical research and development is creating more opportunities for Contract Research Organizations (CROs), many are struggling to keep pace with competitive pressures, changing market requirements, and a lack of skilled talent.  To help CROs meet these challenges, Oracle introduced its CRO Growth Initiative in August 2022. The global program offers CROs no-obligation access to Oracle Clinical One, a leading eClinical platform, for non-production purposes. Through the program, CROs can evaluate, familiarize, train, and enable their users with the technology and demonstrate the power of Clinical One to potential sponsors. Already, hundreds of CRO professionals have taken advantage of the program’s accelerator that provides go-to-market benefits, technical enablers, and incentives all constructed to help them to get trials up and running faster.

Thermo Fisher Scientific Collaborates to Introduce Fully Automated Cell Line Automation Platform

Thermo Fisher Scientific and Celltrio have announced their collaboration to bring a fully automated cell culture system to biotherapeutics customers.

RBQM Market Leader, CluePoints, Celebrates Milestone of De-risking 1000 Clinical Studies

RBQM Market Leader, CluePoints, Celebrates Milestone of De-risking 1000 Clinical Studies Risk-Based Quality Management: 10 Years of enhancing Quality, Accuracy, and Integrity across all Clinical Trial Data

Verisense Health Introduces Eminent New Board of Advisors

Verisense® Health, Inc., a digital health software and data management company, today announced the four founding members of its Board of Advisors – Dr. William Crown, Paul Hartung, Dr. Ronald C. Kessler, and Josh Tolkoff. They bring large-scale medical research, statistical, epidemiological, operational and funding expertise to the company.

Creative Enzymes Introduces Two Enzyme Engineering Methods to Accelerate Related Research

Kidney and Pancreas Function Diagnostic Enzymes Are Now Available at Creative Enzymes

TransCure bioServices offers BioVolume 3D imaging for insightful preclinical oncology research

TransCure bioServices adds BioVolume 3D imaging to its service offerings, enabling them to deliver even higher quality tumor growth results to customers.

Exothera announces the appointment of Darren Leva as Chief Business Officer

Exothera S.A. has announced that it has appointed Darren Leva as Chief Business Officer

AARDEX and Cambridge Cognition Join Forces to Bring Next-Level Adherence Oversight to Hybrid and Decentralized Clinical Trials

AARDEX and Cambridge Cognition Join Forces to Bring Next-Level Adherence Oversight to Hybrid and Decentralized Clinical Trials Seamless integration of adherence and research data protects participant safety and data quality, with no additional burden for clinical trial sites or participants

Alfa Chemistry Newly Releases Photosensitizers, Photocatalysts, and Quantum Dots

Creative Biogene Release Fungal ITS Sequencing to Support Microbial Identification

Microbiosci Designs Pseudomonas Fluorescens Fermentation to Support Clinical Research for Several Disease Disorders

Creative Biogene Launches Bioproduction Cell Line Development to Support The Process of Biopharmaceutical Manufacturing

Creative Bioarray Offers More Than 2,000 Tumor Cells from Human and Animals

Creative Bioarray Constructed More Than 6000 Types of High-quality Tissue Microarrays

DDA Platform Accelerates Drug Discovery Process with Wide Range of Assays and Services

MURAL HEALTH AND LEDGER RUN PARTNER TO STREAMLINE CLINICAL BUSINESS OPERATIONS

MURAL HEALTH, a clinical trials technology company that improves the patient and caregiver experience in order to improve enrollment rates, participant retention, and increase protocol compliance and LEDGER RUN, an innovative technology company focused on optimizing clinical operations, today announced a strategic partnership. Through this partnership, Mural Health’s Mural Link™ platform and Ledger Run’s unique ClinRun™ platform work together to improve clinical operations and materially improve the efficiency, and outcomes, of global clinical trials.